Scarica l'app Stockscreener
7.54
1.69%
-0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$7.67
Aprire:
$7.77
Volume 24 ore:
906.55K
Relative Volume:
0.57
Capitalizzazione di mercato:
$405.88M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-7.54
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
+7.25%
1M Prestazione:
+17.81%
6M Prestazione:
-45.44%
1 anno Prestazione:
-62.52%
Intervallo 1D:
$7.50
$7.96
Intervallo di 1 settimana:
$7.28
$8.01
Portata 52W:
$4.32
$22.83
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
7.54 | 412.88M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-27 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Can trapped investors hope for a rebound in Prothena Corporation plcFree Investment Strategy With Low Risk - Newser
What MACD signals say about Prothena Corporation plcForecast Model for Intraday Buy Signals - Newser
How to escape a deep drawdown in Prothena Corporation plcFree Low Risk High Return Opportunities - Newser
Building trade automation scripts for Prothena Corporation plcBreakout Stock Opportunities with Low Drawdown - Newser
Ranking Prothena Corporation plc among high performing stocks via toolsDividend Strategy Summary With 10-Year Outlook - Newser
Volume spikes in Prothena Corporation plc stock – what they meanFree Safe Entry Stock Watch Suggestions - Newser
How Prothena Corporation plc stock performs during market volatilityLow Exposure Strategy with Sector Analysis - Newser
Trend Reversal Possible in Prothena Corporation plc Charts IndicateSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy - BioSpace
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful - Investing.com India
Prothena (PRTA) Surges on Novo Nordisk's Phase 3 Plans for ATTR Amyloidosis Drug - GuruFocus
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk - TipRanks
Prothena Announces that Novo Nordisk Will Advance Coramitug (For - GuruFocus
Breakthrough: Novo Nordisk Takes Prothena's ATTR Drug to Final Trial Stage with $1.2B Milestone Potential - Stock Titan
Prothena stock price target lowered to $10 at RBC on program discontinuation By Investing.com - Investing.com South Africa
Prothena stock price target lowered to $10 at RBC on program discontinuation - Investing.com Nigeria
PRTA: RBC Capital Maintains Rating, Lowers Price Target | PRTA S - GuruFocus
Prothena’s Losses Grow As Revenue Drops And Programs Wind Down - Finimize
9 Analysts Assess Prothena Corp: What You Need To Know - 富途牛牛
RBC Cuts Price Target on Prothena to $10 From $18, Keeps Sector Perform, Speculative Risk - MarketScreener
Prothena Corp (PRTA) Maintains 'Buy' Rating with $18 Target by C - GuruFocus
JMP reiterates Market Outperform rating on Prothena stock ahead of key data - Investing.com Nigeria
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena Reports Q2 2025 Financial Results and Pipeline Progress - TipRanks
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Prothena Corporation PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Prothena Corp PLC Reports Q2 2025 Earnings: EPS Loss of $2.34, Revenue at $4.4 Million, Both Missing Estimates - GuruFocus
Published on: 2025-08-04 19:53:20 - beatles.ru
How does Prothena Corporation plc generate profit in a changing economyAchieve triple-digit returns with smart investing - Jammu Links News
What is the risk reward ratio of investing in Prothena Corporation plc stockMaster stock selection with insider knowledge - Jammu Links News
How strong is Prothena Corporation plc company’s balance sheetInvest smarter with daily stock recommendations - Jammu Links News
What is Prothena Corporation plc company’s growth strategyCapitalize on market shifts with expert advice - Jammu Links News
What catalysts could drive Prothena Corporation plc stock higher in 2025Accelerate your capital gains today - Jammu Links News
Prothena Corporation plc Stock Analysis and ForecastBuild a portfolio that outperforms consistently - Jammu Links News
What are the latest earnings results for Prothena Corporation plcDiscover high-impact stocks for your portfolio - Jammu Links News
Is This a Bottoming Phase for Prothena Corporation plcLow Drawdown Real Time Trading Tips Shared - beatles.ru
Key resistance and support levels for Prothena Corporation plcRisk-Managed Strategy Based on Price Analysis - Newser
Tools to assess Prothena Corporation plc’s risk profileMarket Opportunity Tracker for Swing Traders - Newser
How volatile is Prothena Corporation plc stock compared to the marketEntry Signal Planner To Watch Now - jammulinksnews.com
Intraday pattern recognizer results for Prothena Corporation plcFree Fast Entry High Potential Stock Alerts - Newser
How many analysts rate Prothena Corporation plc as a “Buy”Pre Market Recommendation With Low Risk - Jammu Links News
Can technical indicators confirm Prothena Corporation plc’s reversalCommunity Picked Stocks with Trade Insights - Newser
Prothena Secures Leadership with New Executive Agreements - The Globe and Mail
Sector ETF performance correlation with Prothena Corporation plcMarket Entry and Exit Point Tips From Traders - metal.it
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):